Reading Time: 2 minutes BRUSSELS (Reuters) – The European Union will meet AstraZeneca executives on Monday to seek further clarification on why they unexpectedly announced a large cut in supplies of COVID-19 vaccine to the bloc for the first quarter of the year, EU officials said. AstraZeneca, which developed its shot with Oxford University, told the
Pexels.com Tista' taqra bil- Malti . The EU will meet the officials of AstraZeneca to get the required clarifications on why they unexpectedly announced a large cut in supplies of COVID-19 vaccine to the EU Member states for the first quarter of the year, according to EU officials quoted by international news agencies. AstraZeneca developed its vaccine
Charles Michel Tista' taqra bil- Malti . European Council President Charles Michel said that the European Union will be making sure that the pharmaceutical companies respect their contractual obligations and deliver the promised vaccines. Michel was speaking on Europe 1 radio. The unreliability of COvid-19 vaccine supply has angered European governments
Prime minister attacks AstraZeneca and BioNTech/Pfizer for lower than expected deliveries Italy’s prime minister has accused AstraZeneca of a “serious contractual violation” for what he said was an unexpected reduction in the number of doses of the company’s Covid-19 vaccine that will be delivered to European Union countries. Giuseppe Conte said that
Reading Time: 2 minutes MILAN, Jan 23 (Reuters) – Italy will have to rethink its COVID-19 vaccination plans if supply problems persist, a senior health official said on Saturday. The country had already had to cut its daily inoculations by more than two thirds because of delays in deliveries of shots from U.S. drugmaker Pfizer Inc, Franco Locatelli,
Photo by Steven Cornfield on Unsplash AstraZeneca will cut its coronavirus vaccine delivery by 60% in the first quarter of this year, Reuters news agency reported. Watch: Malta received less Pfizer doses than planned, Fearne confirms This is the second vaccine manufacturer which has warned of supply issues to the European Union, after Pfizer started
A warning from AstraZeneca that initial supplies of its Covid vaccinations to Europe will be lower than expected has sparked new concern over the rollout of inoculations, with some countries planning for a sharp drop in deliveries. Friday's announcement by the British pharmaceutical firm followed another last week by Pfizer, which said it would delay
Pharmaceutical group says initial volumes will ‘be lower than originally anticipated’ AstraZeneca has warned EU countries to expect significant shortfalls to early deliveries of its coronavirus vaccine, in a fresh blow to the rollout of the bloc’s immunisation programme, European officials have said. The EU was expecting 100m doses of the jab in the
A delay in the rollout of the AstraZeneca coronavirus vaccine will result in a significant shortfall of doses for EU member states. The first deliveries of the vaccine will be “lower than initially anticipated” due to a reduced yield at the pharmaceutical company’s manufacturing site in Belgium, AstraZeneca warned. “We will be supplying tens of millions
British pharmaceutical firm AstraZeneca warned Friday that supplies of its coronavirus vaccine to Europe will be "lower than originally anticipated" due to reduced production at a manufacturing site. The jab it developed with the University of Oxford in England is already being rolled out across the UK, but the European Union has not yet approved its